• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中8号染色体数目畸变及C-MYC拷贝数增加与分期和分级相关。

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.

作者信息

Mahdy E, Pan Y, Wang N, Malmström P U, Ekman P, Bergerheim U

机构信息

Department of Urology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Anticancer Res. 2001 Sep-Oct;21(5):3167-73.

PMID:11848469
Abstract

Chromosome 8 aberration and c-myc amplification have been suggested as playing important roles in the development of different human cancers. Using fluorescence in situ hybridization (FISH), chromosome 8 polysomy and c-myc amplification can be detected in cells from bladder cancer. We investigated the correlation of chromosome 8 polysomy, c-myc gene alteration and p53 deletion with histopathological parameters. Twenty-four tumors obtained from patients with bladder cancer were analyzed by interphase cytogenetics using FISH with chromosome 8 and 17 centromere probes together with an YAC clone covering the c-myc locus and three cosmid DNA probes covering the p53 locus. Chromosome 8 polysomy was found in 12 tumors. The average copy number of chromosome 8 centromere signals were significantly higher in high grade and stage, cancers. Also the c-myc copy gain and p53 deletion were significantly correlated with grade as well as stage (p<0.05, in both cases). Both polysomy 8 and c-myc copy gain were significantly correlated with p53 deletions (p<0.01) and DNA ploidy (p<0.001). On the contrary there was no significant correlation between c-myc protein over-expression and c-myc gene amplification. These results may indicate that alteration of chromosomal regions on 8q and 17p, including c-myc and p53 genes, may be linked to progression of bladder cancer.

摘要

染色体8畸变和c-myc扩增被认为在不同人类癌症的发生发展中起重要作用。使用荧光原位杂交(FISH)技术,可以在膀胱癌细胞中检测到染色体8多体性和c-myc扩增。我们研究了染色体8多体性、c-myc基因改变和p53缺失与组织病理学参数之间的相关性。使用覆盖c-myc基因座的YAC克隆和覆盖p53基因座的三个黏粒DNA探针,对24例膀胱癌患者的肿瘤进行了间期细胞遗传学分析,同时使用了染色体8和17着丝粒探针。在12个肿瘤中发现了染色体8多体性。在高级别和晚期癌症中,染色体8着丝粒信号的平均拷贝数显著更高。此外,c-myc拷贝数增加和p53缺失与分级和分期均显著相关(两种情况均为p<0.05)。8号染色体多体性和c-myc拷贝数增加均与p53缺失(p<0.01)和DNA倍体(p<0.001)显著相关。相反,c-myc蛋白过表达与c-myc基因扩增之间没有显著相关性。这些结果可能表明,包括c-myc和p53基因在内的8q和17p染色体区域的改变可能与膀胱癌的进展有关。

相似文献

1
Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.膀胱癌中8号染色体数目畸变及C-MYC拷贝数增加与分期和分级相关。
Anticancer Res. 2001 Sep-Oct;21(5):3167-73.
2
Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.17号染色体多体在膀胱移行细胞癌中的作用:HER2/neu表达的免疫组化研究及c-erbB-2基因与17号染色体的荧光原位杂交分析
Int J Surg Pathol. 2009 Jun;17(3):198-205. doi: 10.1177/1066896909333415.
3
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.荧光原位杂交法检测转移性前列腺癌中c-myc癌基因扩增及染色体异常
Cancer Res. 1997 Feb 1;57(3):524-31.
4
Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.日本患者TNM分期前列腺癌中c-myc扩增的荧光原位杂交分析
Int J Urol. 2006 Jun;13(6):761-6. doi: 10.1111/j.1442-2042.2006.01399.x.
5
Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.在人类膀胱癌中,7号染色体着丝粒拷贝数与肿瘤分级和标记指数密切相关。
Cancer Res. 1991 Jul 15;51(14):3807-13.
6
Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.膀胱癌中c-erbB-2基因扩增及染色体异常的荧光原位杂交评估
Clin Cancer Res. 2001 Aug;7(8):2463-7.
7
[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].[福尔马林固定膀胱肿瘤中的Ki-67分数、p53改变及染色体数目畸变(7号和17号染色体)]
Verh Dtsch Ges Pathol. 1993;77:226-30.
8
[The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].[激光扫描细胞术测定的DNA倍体类型、p53蛋白过表达与膀胱癌中7号染色体数目畸变之间的关系]
Hinyokika Kiyo. 2000 Jun;46(6):377-83.
9
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.在T(2 - 3)N(1 - 3)M(0)期前列腺癌中,p53缺失和c - myc过度表达是癌症进展的潜在标志物。
Mod Pathol. 2002 Jan;15(1):35-44. doi: 10.1038/modpathol.3880487.
10
Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.通过荧光原位杂交检测葡萄膜黑色素瘤中的c-myc扩增
Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1679-84.

引用本文的文献

1
The roles of FGFR3 and c-MYC in urothelial bladder cancer.FGFR3和c-MYC在膀胱尿路上皮癌中的作用。
Discov Oncol. 2024 Jul 20;15(1):295. doi: 10.1007/s12672-024-01173-z.
2
Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.MYC 和 CEBPD 共扩增在尿路上皮癌中的生物学意义:多层次的基因组、转录和转录后正反馈环增强致癌性糖酵解。
Clin Transl Med. 2021 Dec;11(12):e674. doi: 10.1002/ctm2.674.
3
Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.
c-Myc免疫组化表达在膀胱肌层浸润性尿路上皮癌中的预后价值:一项回顾性研究
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3735-3746. doi: 10.31557/APJCP.2019.20.12.3735.
4
Acts as a Competing Endogenous RNA to Sponge , in the Upregulation of CD44, in Urothelial Carcinoma.作为一种竞争性内源性RNA发挥海绵作用,在尿路上皮癌中上调CD44。
Cancers (Basel). 2019 Sep 28;11(10):1457. doi: 10.3390/cancers11101457.
5
Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.Rab23在人类膀胱癌中过表达,并促进癌细胞增殖和侵袭。
Tumour Biol. 2016 Jun;37(6):8131-8. doi: 10.1007/s13277-015-4590-9. Epub 2015 Dec 29.
6
CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.CEBPD在尿路上皮癌中的扩增和过表达:肿瘤转移的驱动因素及不良预后指标
Oncotarget. 2015 Oct 13;6(31):31069-84. doi: 10.18632/oncotarget.5209.
7
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.β-微管蛋白-3和c-Myc在膀胱肌层浸润性尿路上皮癌中的预后价值
PLoS One. 2015 Jun 5;10(6):e0127908. doi: 10.1371/journal.pone.0127908. eCollection 2015.
8
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.基于全基因组分析,LY6K 是膀胱癌的一个新的分子靶标。
Br J Cancer. 2011 Jan 18;104(2):376-86. doi: 10.1038/sj.bjc.6605990. Epub 2010 Nov 9.
9
Targeted therapies in the management of metastatic bladder cancer.转移性膀胱癌治疗中的靶向疗法。
Biologics. 2007 Dec;1(4):393-406.